Comparison of Neoplastic Cell Percentage of Malignant Mediastinal Lymph Node Tissue Obtained via Endobronchial Ultrasound-Guided Transbronchial Lymph Node Cryobiopsy (EBUS-TBLNC) versus Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)

Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 34 人开始时间: 2025年9月1日最近更新: 2026年8月3日

适应症

试验速览

阶段: 3 期
状态: 进行中（未招募）
发起方: Faculty of Medicine, Chulalongkorn University
入组人数: 34

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The median NCP for EBUS-TBNA was 47.50%, which was numerically higher than the median NCP of 30.00% obtained via EBUS-TBLNC (p 0.082). For the secondary outcomes, the ATC was descriptively lower in the EBUS-TBLNC group (median 2,650 vs. 4,000) and reached a statistically significant difference (p 0.015). The median additional procedural time for EBUS-TBLNC was 11:00 minutes (IQR: 8:00-16:15). Complication is limited to one case of significant hypotension requiring fluid resuscitation.

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 Years 至 N/A (No limit)（—）
性别: All

入选标准

•Individuals aged 18 years and older.
•Suspected or diagnosed with non-small cell lung cancer
•Prior CT scan or PET scan results indicate the presence of at least one mediastinal lymph node measuring no less than 1 cm in short axis, or FDG-PET uptake (SUVmax > 2.5).
•The lymph node is accessible through EBUS.
•Signed informed consent to participate in the research.

排除标准

•Presence of abnormal, uncorrectable bleeding tendencies.
•Severe arrhythmia.
•History of coronary artery disease or unstable angina within 4 weeks prior to the procedure.
•Severe upper airway obstruction which prevents the passage of the EBUS scope.
•Ongoing active heart failure or respiratory failure

研究者

发起方

Faculty of Medicine, Chulalongkorn University

相似试验

尚未招募

不适用

Unveiling ERlow Breast Cancer in India: Insights from a Multicenter Registry and Collaborative Centers on Clinicopathological Characteristics and Clinical Outcomes"

CTRI/2023/11/060352Dr ASHWIN OOMMEN PHILIPS200

尚未招募

3 期

Study to assess if adding Carboplatin before surgery improves Tumor response in Non metastatic TNBC patients .

CTRI/2025/07/091252Dr Karthik Ambalavana48

尚未招募

不适用

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerEsophageal Cancer

NCT07573397Fudan University88

招募中

3 期

A real-world study on how well ribociclib and hormone therapy work together to prevent early breast cancer from coming back.

CTRI/2025/08/092443Novartis Healthcare Pvt Ltd3,100

尚未招募

Phase 3 4

An Ayurvedic Management in improving the Quality of Life in Stage 4 cancer During Chemotherapy

CTRI/2024/08/072245Dr Mahantagouda S40